Keyphrases
Cognitive Impairment
100%
Synaptic Dysfunction
100%
Dentate Gyrus
100%
Experimental Parkinsonism
100%
Novel Object Recognition
75%
Long-term Potentiation
75%
Parkinson's Disease
50%
Synaptic Plasticity
50%
SKF81297
50%
Hippocampus
25%
Mouse Model
25%
Visual Working Memory
25%
Sham
25%
Receptor Agonist
25%
Extracellular Signal-regulated Kinase
25%
Striatum
25%
Cognitive Deficits
25%
Cognitive Performance
25%
Noradrenergic
25%
Parkinson's Disease Model
25%
L-DOPA
25%
Hippocampal CA1 Region
25%
Antiparkinsonian Drugs
25%
Recognition Memory
25%
Non-motor Symptoms
25%
Extracellular Signal-regulated Kinase Signaling
25%
Tremor
25%
Bradykinesia
25%
6-hydroxydopamine (6-OHDA)
25%
Dopamine D2
25%
Dopamine D1 Receptor
25%
Dopamine D1
25%
Noradrenaline
25%
Dopamine Depletion
25%
Nigrostriatal Dopaminergic Pathway
25%
6-hydroxydopamine Lesion
25%
Long-term Recognition
25%
Partial Lesion
25%
Neuroscience
Cognitive Disorders
100%
Parkinsonism
100%
Dentate Gyrus
100%
Parkinson's Disease
75%
Long-Term Potentiation
75%
Hippocampus
50%
Dopaminergic
50%
Synaptic Plasticity
50%
Extracellular Signal-Regulated Kinases
50%
Oxidopamine
50%
L-DOPA
25%
Receptor Agonists
25%
Striatum
25%
Norepinephrine
25%
Tremor
25%
Bradykinesia
25%
Dopamine Receptor D1
25%
Recognition Memory
25%
Receptor
25%
Pharmacology, Toxicology and Pharmaceutical Science
Parkinson's Disease
100%
Cognitive Defect
100%
Experimental Parkinsonism
100%
Dopamine Receptor Stimulating Agent
66%
Mitogen Activated Protein Kinase
66%
Oxidopamine
66%
Receptor
33%
Mouse Model
33%
Receptor Agonist
33%
Noradrenalin
33%
Bradykinesia
33%
Antiparkinson Agent
33%
Dopamine 1 Receptor
33%
DOPA
33%
Biochemistry, Genetics and Molecular Biology
Long Term Potentiation
100%
Dopaminergic
66%
Extracellular Signal-Regulated Kinases
66%
Nerve Cell Plasticity
66%
Mouse Model
33%
Receptor Agonists
33%
Rigidity
33%
Dopamine Receptor D1
33%
Novel Object Recognition Test
33%
Norepinephrine
33%